Apply for MedTech Accelerator Rapid Regulatory Support (MARRS) Programme
The MedTech Accelerator Rapid Regulatory Support (MARRS) Programme provides funding for regulatory approval for new and existing products
APPLICATIONS ARE CLOSED
The MedTech Accelerator: Rapid Regulatory Support Fund (MARRS) is a rapid funding initiative to support UK MedTech SMEs with the costs of regulatory affairs support. Research conducted by CPI uncovered that 9 in 10 SMEs rely on external regulatory support, which is likely to be over 3000 companies. The fund has the capacity to support 140 companies with meeting regulatory requirements. Up to 300 completed applications can be reviewed to enable rapid funding timelines. To ensure fairness and consistency of the rules for everyone interested in the programme, the competition was closed after we reached the target number of applications, and no further applications were accepted.
CPI works with innovators to support the development and pilot manufacture of innovative products. Therefore, we appreciate how impactful and helpful this type of funding can be for UK SMEs.
Please complete this form to be kept informed of similar programmes and our other activities.
We are also offering two other support programmes which may be of interest to you.
- Patient Flow Innovations for up to £50,000 in development support for digital innovations
- Internet of Caring Things to support businesses in innovating for the ageing population.
Competition summary
The programme will support SMEs that rely on external expertise to commercialise new products or re-register existing products in line with new regulatory requirements. SMEs working in HealthTech can apply for up to £30,000 of funding for use with regulatory affairs providers to help with navigating regulatory pathways.
There is a total of £4.2m Innovate UK investment, with projects to be awarded up to £30,000.
Competition summary
The programme will support SMEs that rely on external expertise to commercialise new products or re-register existing products in line with new regulatory requirements. SMEs working in HealthTech can apply for up to £30,000 of funding for use with regulatory affairs providers to help with navigating regulatory pathways.
There is a total of £4.2m Innovate UK investment, with projects to be awarded up to £30,000.
Competition aim
On behalf of the UK Government’s Office for Life Sciences, CPI has created the MedTech Accelerator: Rapid Regulatory Support fund. It has been developed to help small and medium-sized business to navigate the complex and ever-changing MedTech regulatory landscape.
The programme will support SMEs who rely on external expertise to commercialise new products, or re-register existing products in line with new regulatory requirements.
Building on the success of the HealthTech Regulatory Innovation Programme (HealthTRIP) funded by Innovate UK in 2022, we aim to again support hundreds of UK SMEs to overcome regulatory hurdles. The HealthTRIP project awarded funding to 277 companies, find out more here: https://www.uk-cpi.com/healthtrip
Find out more
Check your eligibility, read our FAQs and find out more about the scope here.
Competition scope
Applications open on Tuesday, October 8th, 2024, at 9 a.m. and close on Thursday, October 31st, 2024, at midday. We will review applications regularly, and if we receive 300 before the deadline, we will close applications early. Companies are, therefore, encouraged to apply as soon as they can.
Funding is aimed at SMEs developing or offering products in the medical device and diagnostics (including IVD) area. Although pharma products are not considered under this guidance, combination medical products such as drug delivery devices would be considered eligible.
Why you should apply
The regulatory landscape for HealthTech is constantly changing, including a divergence between the UK and EU systems. This is leading to some UK companies finding their products no longer meet the regulatory requirements to be sold within the EU. SMEs seeking to commercialise their products often suffer from a lack of internal expertise on regulatory process, leading to a reliance on external support. This presents a financial and knowledge barrier to many small businesses. The Health Technology Regulatory and Innovation Programme aims to help SMEs overcome this barrier.
Let’s innovate together
To find out more about how we can work together, please enter your details below.